Avsar.
SU

Healthcare · Healthcare Service Provider

Suraksha Diagnostic Ltd (SURAKSHA)

₹325.40

Mkt cap
₹1,745 Cr
P/E ratio
48.80
P/B
6.92
Div yield
0.15%
ROE
14.20%
ROCE
17.30%
EPS (TTM)
₹6.67
Book value
₹47
52W range
224–360
Sector
Healthcare

Price history

Previous close

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution. [1]

NSE SURAKSHABSE 544293
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−9.61% from high
₹325
₹224+45.20% from low₹360
Current
₹325.40
Prev close
₹331.00
Day
−1.69%
Price performance
1D
−1.69%
1W
−6.24%
1M
−4.18%
3M
+20.81%
6M
+32.83%
1Y
+9.19%
YTD
+17.62%

Financials

Revenue, profit & margin
P/E ratio
48.8×
SURAKSHA is 34% above the sector median of 36.5×
SURAKSHA48.8×
Sector median36.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales605255616760657379788188
Expenses393636404441464955555757
Operating Profit211519212318192424232430
OPM %35%30%35%34%35%31%29%33%31%30%30%35%
Other Income110111111111
Interest222222233344
Depreciation8889999910111111
Profit before tax11691114891212101017
Tax %24%27%32%27%26%26%22%26%27%28%38%22%
Net Profit85681067997613
EPS in Rs121.8867.3994.491.842.401.181.421.801.731.441.212.50
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +12.61% · closed higher next day 1 of last 1
 Q1FY27
Broadcast12 Aug '26
Earnings day+12.61%
+1 day+12.78%
+5 days+12.87%
+15 days+25.61%
+30 days+26.98%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Jun 2026
49.10%Promoter
Promoters49.10%
FIIs13.47%
DIIs23.22%0.08
Public14.20%0.11
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Dr Lal Pathlabs₹1,896.9056.6331,8390.74%171+28.02%798+19.10%28.00%
Vijaya Diagnost.₹1,558.9085.6416,0560.13%53+37.60%231+22.83%20.53%
Metropolis Healt₹597.4559.5512,3940.33%57+25.77%450+16.62%17.81%
Thyrocare Tech.₹555.8048.958,8461.68%51+34.06%240+24.34%35.38%
Nephrocare Health Services₹743.3587.837,4750.00%32+34.89%282+23.69%15.34%
Krsnaa Diagnost.₹541.1517.741,7550.37%16−19.12%211+19.95%12.70%
Suraksha Diagno.₹335.1048.751,7450.15%13+38.40%88+20.75%17.29%
Median: 17 Co.₹335.1036.541,0530.00%11+28.02%95+19.10%20.53%

Filings

Annual reports2
Annual Report 2026Annual Report 2025
Concall transcripts19
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptMay 2026PPTMay 2026TranscriptFeb 2026PPTFeb 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptAug 2025PPTAug 2025TranscriptJun 2025PPTJun 2025TranscriptFeb 2025PPTFeb 2025TranscriptDec 2024PPTDec 2024PPTDec 2024
Credit ratings1
Rating update 8 Oct 2025crisil
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Aug - The Newspaper Advertisement published on Monday, 31st August, 2026 with respect to the "Notice of 21st Annual General Meeting and e-voting information."Intimation Under Regulation 30 And 36(1)(B) Of The SEBI (LODR) Regulations, 2015 (SEBI Listing Regulations) 27 Aug - 21st AGM on 22 September 2026; annual report sent, dividend record date 15 September 2026.Notice For The 21St Annual General Meeting (AGM) Of The Company 27 Aug - Annual Report FY2025-26 and notice for 21st AGM on 22 September 2026 released.Reg. 34 (1) Annual Report. 27 AugAnnouncement under Regulation 30 (LODR)-Newspaper Publication 25 Aug - Newspaper Publication for Notice of the 21st Annual General Meeting(AGM) of the Company